| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Advances made in the treatment of testicular cancer in the U.S. Military: 1946 to the present
|
Hawksworth, Dorota J.
|
|
2009
|
27 |
5 |
p. 553-557
5 p.
|
artikel
|
| 2 |
A single institution experience with biochemical recurrence after radical prostatectomy for tumors that on pathology are of small volume or “insignificant”
|
van Oort, I.M.
|
|
2009
|
27 |
5 |
p. 509-513
5 p.
|
artikel
|
| 3 |
Clinical use of serum CA-125 levels in patients undergoing radical cystectomy for transitional cell carcinoma of the bladder
|
Kouba, Erik J.
|
|
2009
|
27 |
5 |
p. 486-490
5 p.
|
artikel
|
| 4 |
Commentary on A double-blind randomized crossover study of oral thalidomide versus placebo for androgen dependent prostate cancer treated with intermittent androgen ablation
|
Trump, Donald L.
|
|
2009
|
27 |
5 |
p. 571-
1 p.
|
artikel
|
| 5 |
Commentary on Antitumor effects of an imidazoquinoline in renal cell carcinoma
|
Slaton, Joel W.
|
|
2009
|
27 |
5 |
p. 581-
1 p.
|
artikel
|
| 6 |
Commentary on Bevacizumab plus interferonα compared with interferonα monotherapy in patients with metastatic renal cell carcinoma: CALGB 90206
|
Trump, Donald L.
|
|
2009
|
27 |
5 |
p. 571-572
2 p.
|
artikel
|
| 7 |
Commentary on Cancer survivors and unemployment: A meta-analysis and meta-regression
|
Hollenbeck, Brent K.
|
|
2009
|
27 |
5 |
p. 577-
1 p.
|
artikel
|
| 8 |
Commentary on Factors predicting health-related quality of life recovery in patients undergoing surgical treatment for renal tumors: Prospective evaluation using the RAND SF-36 health survey
|
Hollenbeck, Brent K.
|
|
2009
|
27 |
5 |
p. 575-576
2 p.
|
artikel
|
| 9 |
Commentary on Lack of comprehension of common prostate cancer terms in an underserved population
|
Hollenbeck, Brent K.
|
|
2009
|
27 |
5 |
p. 576-
1 p.
|
artikel
|
| 10 |
Commentary on Lack of pathologic down-staging with neoadjuvant chemotherapy for muscle-invasive urothelial carcinoma of the bladder: A contemporary series
|
Trump, Donald L.
|
|
2009
|
27 |
5 |
p. 574-
1 p.
|
artikel
|
| 11 |
Commentary on MicroRNA profiling of human kidney cancer subtypes
|
Slaton, Joel W.
|
|
2009
|
27 |
5 |
p. 579-580
2 p.
|
artikel
|
| 12 |
Commentary on Phase III trial of androgen ablation with or without three cycles of systemic chemotherapy for advanced prostate cancer
|
Trump, Donald L.
|
|
2009
|
27 |
5 |
p. 574-575
2 p.
|
artikel
|
| 13 |
Commentary on Prostate cancer severity among low income, uninsured men
|
Hollenbeck, Brent K.
|
|
2009
|
27 |
5 |
p. 577-578
2 p.
|
artikel
|
| 14 |
Commentary on Provider case volume and outcomes following prostate brachytherapy
|
Hollenbeck, Brent K.
|
|
2009
|
27 |
5 |
p. 575-
1 p.
|
artikel
|
| 15 |
Commentary on Randomized phase II trial of first-line treatment with sorafenib vs. interferonα-2a in patients with metastatic renal cell carcinoma
|
Trump, Donald L.
|
|
2009
|
27 |
5 |
p. 572-
1 p.
|
artikel
|
| 16 |
Commentary on Response of the primary tumor to neoadjuvant sunitinib in patients with advanced renal cell carcinoma
|
Trump, Donald L.
|
|
2009
|
27 |
5 |
p. 573-
1 p.
|
artikel
|
| 17 |
Commentary on Sequential therapy with sorafenib and sunitinib in renal cell carcinoma
|
Trump, Donald L.
|
|
2009
|
27 |
5 |
p. 573-
1 p.
|
artikel
|
| 18 |
Commentary on Specific reduction of Fas-associated protein with death domain (FADD) in clear cell renal cell carcinoma
|
Slaton, Joel W.
|
|
2009
|
27 |
5 |
p. 580-
1 p.
|
artikel
|
| 19 |
Commentary on Telomere length in peripheral blood predicts survival in clear cell renal cell carcinoma
|
Slaton, Joel W.
|
|
2009
|
27 |
5 |
p. 578-
1 p.
|
artikel
|
| 20 |
Commentary on Urine metabolomics analysis for kidney cancer detection and biomarker discovery
|
Slaton, Joel W.
|
|
2009
|
27 |
5 |
p. 578-579
2 p.
|
artikel
|
| 21 |
Commentary on Validation of the type 1 insulin-like growth factor receptor as a therapeutic target in renal cancer
|
Slaton, Joel W.
|
|
2009
|
27 |
5 |
p. 580-581
2 p.
|
artikel
|
| 22 |
Contents
|
|
|
2009
|
27 |
5 |
p. iv-vi
nvt p.
|
artikel
|
| 23 |
Editorial Board
|
|
|
2009
|
27 |
5 |
p. i-
1 p.
|
artikel
|
| 24 |
EGFR mutation in kidney carcinoma confers sensitivity to gefitinib treatment: A case report
|
Iyevleva, Aglaya G.
|
|
2009
|
27 |
5 |
p. 548-550
3 p.
|
artikel
|
| 25 |
Genetic profile identification in clinically localized prostate carcinoma
|
Gallucci, Michele
|
|
2009
|
27 |
5 |
p. 502-508
7 p.
|
artikel
|
| 26 |
Information for Authors
|
|
|
2009
|
27 |
5 |
p. IBC-
1 p.
|
artikel
|
| 27 |
Innovations in urology from military medicine
|
Moul, Judd W.
|
|
2009
|
27 |
5 |
p. 551-552
2 p.
|
artikel
|
| 28 |
Intraoperative frozen biopsy in wide surgical excision of Paget's disease of the scrotum
|
Xu, Ke
|
|
2009
|
27 |
5 |
p. 483-485
3 p.
|
artikel
|
| 29 |
Management of Stage II testicular seminoma over a period of 40 years
|
Detti, Beatrice
|
|
2009
|
27 |
5 |
p. 534-538
5 p.
|
artikel
|
| 30 |
Masthead
|
|
|
2009
|
27 |
5 |
p. IFC-
1 p.
|
artikel
|
| 31 |
Phase II study of intravesical therapy with AD32 in patients with papillary urothelial carcinoma or carcinoma in situ (CIS) refractory to prior therapy with bacillus Calmette-Guerin (E3897): A trial of the Eastern Cooperative Oncology Group
|
Ignatoff, Jeffrey M.
|
|
2009
|
27 |
5 |
p. 496-501
6 p.
|
artikel
|
| 32 |
Preoperative hydronephrosis as an indicator of survival after radical cystectomy
|
Chapman, Darren M.
|
|
2009
|
27 |
5 |
p. 491-495
5 p.
|
artikel
|
| 33 |
Prostate carcinoma spatial distribution patterns in Chinese men investigated with systematic transperineal ultrasound guided 11-region biopsy
|
Yan, Weigang
|
|
2009
|
27 |
5 |
p. 520-524
5 p.
|
artikel
|
| 34 |
Prostate-sparing cystectomy: A review of the oncologic and functional outcomes. Contraindicated in patients with bladder cancer
|
Stein, John P.
|
|
2009
|
27 |
5 |
p. 466-472
7 p.
|
artikel
|
| 35 |
Prostate tumor alignment and continuous, real-time adaptive radiation therapy using electromagnetic fiducials: Clinical and cost-utility analyses
|
Quigley, Martin M.
|
|
2009
|
27 |
5 |
p. 473-482
10 p.
|
artikel
|
| 36 |
PSMA expression in Schwannoma: A potential clinical mimicker of metastatic prostate carcinoma
|
Wang, Wenle
|
|
2009
|
27 |
5 |
p. 525-528
4 p.
|
artikel
|
| 37 |
Relook TURBT in superficial bladder cancer: Its importance and its correlation with the tumor ploidy
|
Dwivedi, Udai S.
|
|
2009
|
27 |
5 |
p. 514-519
6 p.
|
artikel
|
| 38 |
Review of the bylaws changes from the Society of Urologic Oncology 2009
|
Holzbeierlein, Jeffrey M.
|
|
2009
|
27 |
5 |
p. 465-
1 p.
|
artikel
|
| 39 |
Robotic-assisted laparoscopic and radical retropubic prostatectomy generate similar positive margin rates in low and intermediate risk patients
|
Laurila, Timo A.J.
|
|
2009
|
27 |
5 |
p. 529-533
5 p.
|
artikel
|
| 40 |
Survey Section Editorial Board
|
|
|
2009
|
27 |
5 |
p. 570-
1 p.
|
artikel
|
| 41 |
The center for prostate disease research (CPDR): A multidisciplinary approach to translational research
|
Brassell, Stephen A.
|
|
2009
|
27 |
5 |
p. 562-569
8 p.
|
artikel
|
| 42 |
Tissue-selective RNA interference in prostate cancer cell using prostate specific membrane antigen promoter/enhancer
|
Zhao, Weiming
|
|
2009
|
27 |
5 |
p. 539-547
9 p.
|
artikel
|
| 43 |
United States military contributions to the National Cancer Institute
|
Sarvis, Jamey A.
|
|
2009
|
27 |
5 |
p. 558-561
4 p.
|
artikel
|
Tijdschrift beschrijving